NSE · AI Signal & Stock Analysis · Bullish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for JUBLPHARMA is Bullish ↑ (moderate move); technical trend down-trend; trading at ₹950.30 (+2.79% today); neutral (RSI 61).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bullish ↑ · Moderate move |
|---|---|
| Technical trend | Down-trend (since 2026-07-22) |
| Price | ₹950.30 |
| Change today | +2.79% |
| RSI (14) | 61.40 |
| Relative volume | 1.72 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹16,796 Cr |
| P/E | 48.31 |
| Cap category | Mid Cap |
| 52-week high | -19.6% away |
| 52-week low | +17.7% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for JUBLPHARMA (Jubilant Pharmova Limited) is Bullish with a moderate move, and its technical trend is down-trend. The composite score and full factor breakdown are available to signed-in members.
JUBLPHARMA's RSI is neutral (RSI 61). A reading above 70 is typically overbought and below 30 oversold.
JUBLPHARMA is trading about 20% below its 52-week high and 18% above its 52-week low as of Sep 28 2026, 6:47 PM.
JUBLPHARMA's market capitalisation is ₹16,796 Cr as of Sep 28 2026, 6:47 PM.
JUBLPHARMA is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for JUBLPHARMA — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.